Participants in the PREHABILITA study are patients who have to undergo resection surgery for a brain tumour and who start a protocol based on a double intervention:
1) Prehabilitation: inducing structural changes in the brain that allow the appearance of a new functional capacity before surgery. In this way, the compromised neurological function is partially or totally “transferred” to brain areas that will not be affected by tumour resection. This is done by:
- Neuromodulation sessions (TMS or tDCS) that allow the plastic capacity of the nervous system to be optimised, guiding the establishment of new connections towards their maximum functional capacity
- Motor, cognitive or language training tasks that are personalised and specifically aimed at treating functionality that may be compromised by surgery
2) Neurorehabilitation: allowing sensory, motor and cognitive neurological sequelae that may appear after surgery to be minimised, as well as the cognitive impact derived from the tumour itself.
Prehabilitation and neurorehabilitation interventions alike require sufficient intensity and time to produce and consolidate the structural plastic changes that give rise to the appearance of new functional capacity. PREHABILITA’s objective is therefore to assess the feasibility and efficacy of this non-invasive prehabilitation protocol.